Cbd and mental health
Pro Research Analysisby 
Searched over 200M research papers
CBD and Psychiatric Disorders: Evidence Overview
Research into cannabidiol (CBD) and its effects on mental health has grown rapidly, with studies exploring its potential benefits for a range of psychiatric conditions. CBD is generally considered to have a favorable safety profile and does not carry the abuse risk associated with THC, another major cannabis compound 1345+1 MORE.
CBD for Schizophrenia, Psychosis, and Cognitive Impairment
Multiple studies indicate that CBD may help reduce psychotic symptoms and cognitive impairment, particularly in schizophrenia and related disorders. Evidence suggests that CBD can act as an antipsychotic, possibly by modulating the endocannabinoid system and serotonin receptors 1234+1 MORE. Some clinical trials have shown that CBD can reduce the risk of THC-induced paranoia and memory impairment, supporting its protective role in mental health . However, while these findings are promising, more large-scale, long-term studies are needed to confirm efficacy and safety 1234+2 MORE.
CBD and Anxiety Disorders
CBD has shown potential in reducing anxiety symptoms in both animal and human studies. Preliminary clinical trials and systematic reviews report that CBD may have anxiolytic (anxiety-reducing) effects, especially in social anxiety disorder 2345+2 MORE. Most studies report that CBD is well tolerated and safe, but the evidence is still limited, and more research is needed to determine optimal dosing and long-term effects, especially in diverse populations 1234+2 MORE.
CBD for Substance Use Disorders
There is moderate evidence that CBD and CBD-containing compounds can help alleviate symptoms of cannabis withdrawal and reduce dependence on cannabis and tobacco 1246. These effects are thought to be due to CBD’s influence on the endocannabinoid, serotonergic, and glutamatergic systems . However, the number of high-quality studies is still small, and further research is required 124.
CBD and Other Psychiatric Conditions
CBD has been studied for its effects on autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), insomnia, bipolar disorder, post-traumatic stress disorder (PTSD), and Tourette syndrome. The evidence for these conditions is weaker, with only a few studies showing moderate benefits for ASD and ADHD, and even less support for insomnia, bipolar disorder, PTSD, and Tourette syndrome 1256. There is currently not enough high-quality evidence to recommend CBD for depression, dementia, or borderline personality disorder 1257.
CBD and Cognitive Function
Some randomized trials suggest that CBD may improve cognitive impairments and anxiety, with a good safety profile and no evidence of addiction . However, results are mixed, and factors such as dose, formulation, and study design may influence outcomes. More research is needed to clarify CBD’s role in treating neurocognitive disorders .
Safety and Tolerability of CBD
Across studies, CBD is generally reported to be safe and well tolerated, with few adverse effects and no evidence of abuse or dependence 1234+3 MORE. However, the long-term safety of CBD, especially in vulnerable populations, remains to be fully established 1234+2 MORE.
Conclusion
CBD shows promise as a treatment for certain psychiatric conditions, particularly schizophrenia, anxiety, and substance use disorders, with a generally favorable safety profile. However, the current evidence base is limited, and more large, well-designed clinical trials are needed to confirm its efficacy, determine optimal dosing, and assess long-term safety across different mental health conditions. Until then, CBD should be considered a potential, but not yet fully established, option for mental health treatment.
Sources and full results
Most relevant research papers on this topic